skip to main content

Montelukast mood effects — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyRespiratory TherapeuticsMontelukast mood effectsGPhC CRA

A parent reports nightmares and mood changes in a child two weeks after starting montelukast. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BAdvise prompt prescriber review because montelukast can cause neuropsychiatric adverse effects

Sleep and mood changes are recognised montelukast adverse effects requiring review. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.

Reference: BNF; MHRA